Clinical trials in Dobris

7 clinical trials in Dobris, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in CzechiaKlinickeTesty.cz

Dobris at a glance

clinical trials

Recruiting now0
Paediatric trials0
Research sites0

Quick filters

7 trials in Dobris

Open in trial search

Type 2 diabetes mellitus

Not yet recruiting

Evaluation of Long-Term Efficacy and Safety of Tirzepatide Versus Intensified Conventional Care in Early Treatment of Type 2 Diabetes in Adults

Registered drugNo placebo

Evaluation of Long-Term Efficacy and Safety of Tirzepatide Versus Intensified Conventional Care in Early Treatment of Type 2 Diabetes in Adults

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Albiglutide
Sponsor:Eli Lilly & Co.

Contact Research Centre

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational

Czechia

Participants:18–64 years · 65+ years
Sponsor:Amgen Inc.

Contact Research Centre

Familial hypertriglyceridaemia+1

Not recruiting

Study of ISIS 678354 for Patients with Severe High Triglycerides

Investigational

Study of ISIS 678354 for Patients with Severe High Triglycerides

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:ISIS 678354 sodium salt
Sponsor:Ionis Pharmaceuticals Inc.

Contact Research Centre

Hypertriglyceridaemia+1

Not recruiting

Study of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides

Investigational

Study of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:ISIS 678354 sodium salt
Sponsor:Ionis Pharmaceuticals Inc.

Contact Research Centre

Diabetic neuropathy

Not recruiting

Study of LY3556050 for Adults with Diabetic Peripheral Neuropathy Pain

Investigational

Study of LY3556050 for Adults with Diabetic Peripheral Neuropathy Pain

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:LY3556050
Sponsor:Eli Lilly & Co.

Contact Research Centre

Type 2 diabetes mellitus+2

Not recruiting

Study of LY3502970 for Adults with Obesity or Overweight and Type 2 Diabetes

Investigational

Study of LY3502970 for Adults with Obesity or Overweight and Type 2 Diabetes

Investigational

Czechia

Participants:18–64 years · 65+ years
Sponsor:Eli Lilly & Co.

Contact Research Centre

Type 2 diabetes mellitus+3

Not recruiting

Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

Registered drugNo placebo

Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Canagliflozin
Sponsor:Eli Lilly & Co.

Contact Research Centre

Other cities in Czechia

The busiest research cities in the country

All 159 cities in Czechia

Clinical research in Dobris

What the registry says about research in the country

01 Metabolic Disorders

Innovative research focusing on Type 2 Diabetes management and treatment optimization, including studies evaluating new oral medications against conventional therapies.

Diabetes Management
Blood Sugar Control
Long-term Treatment Efficacy

Comparative studies examining the effectiveness of novel therapeutic approaches in maintaining glycemic control.

02 Weight Management

Clinical investigations exploring treatments for obesity and overweight conditions, particularly in patients with concurrent metabolic disorders.

Weight Reduction Therapies
Metabolic Health
Combined Treatment Approaches

Studies evaluating new therapeutic options for weight management in complex medical conditions.

03 Cardiovascular Health

Research targeting cardiovascular diseases and related conditions, including studies on hypertriglyceridemia and atherosclerosis management.

Lipid Management
Cardiovascular Risk Reduction
Atherosclerosis Treatment

Innovative trials exploring new approaches to improve cardiovascular outcomes and reduce disease progression.

Back to Czechia All countries